Navigation Links
Gerresheimer Finalises Purchase of Spanish Company EDP
Date:1/28/2008

DUSSELDORF, Germany, January 28 /PRNewswire-FirstCall/ -- Gerresheimer AG has quickly completed the takeover of the Spanish PET specialist EDP. The Dusseldorf manufacturer of glass and plastic products for the pharmaceutics and life-science industry announced the purchase, through which it continues its global expansion, on 21 December 2007. EDP with production plants in Spain (Zaragoza and Valencia) and Argentina (Buenos Aires) specialises in pharma containers based on PET, and currently achieves annual sales of around EUR32 million.

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 38 production sites in Europe, America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

e-mail: b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
2. Linnartz New Head of Investor Relations of Gerresheimer
3. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
4. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
5. Uninsured Massachusetts Consumer Who Cannot Afford Mandatory Purchase of Health Insurance Flies 3,000 Miles to Speak Out; Is Thrown Out Of Capitol By Speaker Nunez
6. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
7. New Poll: Only 16% of Californians Support Mandatory Purchase of Private Health Insurance; 71% Behind Regulation of Premium Increases
8. AHRQ Releases Consumer Financial Incentives Guide for Employers and Other Health Care Purchasers
9. Stimulating the appetite can lead to unrelated impulse purchases
10. Contact lenses purchased over Internet may place individuals at risk for harmful eyecare practices
11. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at ... Oat is recognized globally as one of the healthiest cereals, XieQingkui, the founder of ... a move to sow the seed of good karma. Buddhism spirit featuring benevolence and ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, ... experience the freedom of recovery, they often feel shame for having struggled with an ... disorder (PTSD). In the workshop, “Rising Strong in Life After an Eating Disorder” -- ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body care ... announced the company had a successful visit to the 2017 ECRM Diet, Vitamin & ... that work in the nutritional, sports and health industries a chance to meet in ...
(Date:1/20/2017)... , ... January 20, 2017 , ... International Protein, a ... and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton Head, ... nutritional scientist who was determined to create a line of products that would elevate ...
(Date:1/20/2017)... ... , ... “The Angel”: a heartwarming and earnest tale of faith and ... children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional ... writer. , When asked of her new book, Marjorie says, “‘The Angel’ was written ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
Breaking Medicine Technology: